Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.
about
Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.Management of impulse control disorders in Parkinson's disease: Controversies and future approachesMarijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.Management of anxiety and motor symptoms in Parkinson's disease.Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease.Treatment of the later stages of Parkinson's disease - pharmacological approaches now and in the future.Neuropsychiatric Issues in Parkinson's Disease.Parkinson's disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists.Behavioral phenotypes associated with MPTP induction of partial lesions in common marmosets (Callithrix jacchus).Editorial: Neurotherapeutics of movement disorders.The impact of motor symptoms on self-reported anxiety in Parkinson's disease.Unilateral ultra-brief pulse electroconvulsive therapy for depression in Parkinson's disease.Temporal Dissociation of Striatum and Prefrontal Cortex Uncouples Anhedonia and Defense Behaviors Relevant to Depression in 6-OHDA-Lesioned Rats.Cognitive Behavior Therapy for Anxiety in Parkinson's Disease: Outcomes for Patients and Caregivers.Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment.
P2860
Q33771694-98F08BBD-F347-4C1F-8EB4-4C24B5C605E0Q37361959-2FE94C2D-C58E-41EF-B2ED-C6762D9C4749Q37512670-755C472A-E6F3-4C10-AC2E-DED5CF3AA30EQ38233285-A352121F-B63B-4D60-B55C-3DAD3563B1BBQ38258699-4EF225AB-4339-44CB-9B03-BEB10165F24CQ38478999-693AC550-47DB-41B4-B0B1-915667D2311AQ38799051-2FA9DC26-57FC-4CF7-82D4-E14F5DD21B2CQ38894971-54790DA3-D0DE-4AE9-9BC0-034E564C00B6Q38951302-6A223AED-627C-4E96-9C0B-B4701C54B7CDQ42736439-A253FC1F-843D-4E62-A4A0-9FBCB1CE5939Q47338795-6B3508B4-2D42-431A-BADD-AD12D88A2DC5Q48053905-B1C2269C-F6DE-4A45-A8F9-146315F1CD81Q50891658-A1731E4A-619E-43F2-92C5-86C55E4373BDQ53500441-D0B8749B-9281-4DD1-8D59-E2C60C94263BQ55424779-2693DE42-AF46-4C20-AD33-752486A51137
P2860
Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Treatment of cognitive, psychi ...... ated with Parkinson's disease.
@ast
Treatment of cognitive, psychi ...... ated with Parkinson's disease.
@en
Treatment of cognitive, psychi ...... ated with Parkinson's disease.
@nl
type
label
Treatment of cognitive, psychi ...... ated with Parkinson's disease.
@ast
Treatment of cognitive, psychi ...... ated with Parkinson's disease.
@en
Treatment of cognitive, psychi ...... ated with Parkinson's disease.
@nl
prefLabel
Treatment of cognitive, psychi ...... ated with Parkinson's disease.
@ast
Treatment of cognitive, psychi ...... ated with Parkinson's disease.
@en
Treatment of cognitive, psychi ...... ated with Parkinson's disease.
@nl
P2860
P1433
P1476
Treatment of cognitive, psychi ...... ated with Parkinson's disease.
@en
P2093
Barbara Connolly
P2860
P2888
P356
10.1007/S13311-013-0238-X
P50
P577
2014-01-01T00:00:00Z